<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Neurol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Neurol</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Neurology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1664-2295</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">35812093</article-id>
      <article-id pub-id-type="pmc">9259934</article-id>
      <article-id pub-id-type="doi">10.3389/fneur.2022.902912</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Neurology</subject>
          <subj-group>
            <subject>Original Research</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Altered Long- and Short-Range Functional Connectivity Density in Patients With Thyroid-Associated Ophthalmopathy: A Resting-State fMRI Study</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>Wen-Hao</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="fn002" ref-type="author-notes">
<sup>†</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Huan-Huan</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref>
          <xref rid="fn002" ref-type="author-notes">
<sup>†</sup>
</xref>
          <uri xlink:href="http://loop.frontiersin.org/people/1585872/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Wen</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref>
          <uri xlink:href="http://loop.frontiersin.org/people/1490769/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>Qian</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Lu</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>Jiang</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>Xiao-Quan</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref>
          <uri xlink:href="http://loop.frontiersin.org/people/1148766/overview"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Hu</surname>
            <given-names>Hao</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="c002" ref-type="corresp">
<sup>*</sup>
</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Wu</surname>
            <given-names>Fei-Yun</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref>
          <uri xlink:href="http://loop.frontiersin.org/people/982168/overview"/>
        </contrib>
      </contrib-group>
      <aff id="aff1"><sup>1</sup><institution>Department of Radiology, The First Affiliated Hospital of Nanjing Medical University</institution>, <addr-line>Nanjing</addr-line>, <country>China</country></aff>
      <aff id="aff2"><sup>2</sup><institution>Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University</institution>, <addr-line>Nanjing</addr-line>, <country>China</country></aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: Fuchun Lin, Innovation Academy for Precision Measurement Science and Technology (CAS), China</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: Zhaohui Liu, Capital Medical University, China; Ting Li, Capital Medical University, China</p>
        </fn>
        <corresp id="c001">*Correspondence: Fei-Yun Wu <email>wfy_njmu@163.com</email></corresp>
        <corresp id="c002">Hao Hu <email>haohu_njmu@foxmail.com</email></corresp>
        <fn fn-type="other" id="fn001">
          <p>This article was submitted to Applied Neuroimaging, a section of the journal Frontiers in Neurology</p>
        </fn>
        <fn fn-type="equal" id="fn002">
          <p>†These authors have contributed equally to this work</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>23</day>
        <month>6</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2022</year>
      </pub-date>
      <volume>13</volume>
      <elocation-id>902912</elocation-id>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>4</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>5</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2022 Jiang, Chen, Chen, Wu, Chen, Zhou, Xu, Hu and Wu.</copyright-statement>
        <copyright-year>2022</copyright-year>
        <copyright-holder>Jiang, Chen, Chen, Wu, Chen, Zhou, Xu, Hu and Wu</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background and Purpose</title>
          <p>Although previous neuroimaging studies have demonstrated emotion- and psychology-associated brain abnormalities in patients with thyroid-associated ophthalmopathy (TAO), the changes of brain functional connectivity in TAO were seldom focused. We aimed to investigate interregional and intraregional functional interactions in patients with TAO by using resting-state functional MRI (rs-fMRI) with long- and short-range functional connectivity density (FCD) analysis.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>Thirty patients with TAO and 30 well-matched healthy controls (HCs) were recruited in our study. Long- and short-range FCD values were calculated and compared between the two groups. Correlations between long- and short-range FCD values and clinical indicators were analyzed.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Compared with HCs, patients with showed both increased long- and short-range FCDs in the left middle frontal gyrus (MFG), orbital part of superior frontal gyrus (ORBsup), and dorsolateral part of superior frontal gyrus (SFGdor); meanwhile, both decreased long- and short-range FCDs in bilateral postcentral gyrus (PoCG), left superior parietal gyrus (SPG), and inferior parietal (IPL). In addition, patients with TAO showed increased short-range FCD in the right SFGdor, bilateral medial part of superior frontal gyrus (SFGmed), left orbital part of middle frontal gyrus (ORBmid), and orbital part of inferior frontal gyrus (ORBinf), as well as decreased short-range FCD in the right supplementary motor area (SMA) and the left paracentral lobule (PCL) than HCs. Moreover, the short-range value in the left SFGdor showed a negative correlation with Montreal Cognitive Assessment (MoCA) score (<italic>r</italic> = −0.501, <italic>p</italic> = 0.005).</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Our findings complemented the functional neural mechanism of TAO, and provided potential neuroimaging markers for assessing the psychiatric, visual, and emotional disturbances in patients with TAO.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>thyroid-associated ophthalmopathy</kwd>
        <kwd>resting-state functional magnetic resonance imaging</kwd>
        <kwd>functional connectivity density</kwd>
        <kwd>prefrontal cortex</kwd>
        <kwd>parietal lobe</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source id="cn001">
            <institution-wrap>
              <institution>National Natural Science Foundation of China</institution>
              <institution-id institution-id-type="doi">10.13039/501100001809</institution-id>
            </institution-wrap>
          </funding-source>
        </award-group>
      </funding-group>
      <counts>
        <fig-count count="3"/>
        <table-count count="2"/>
        <equation-count count="0"/>
        <ref-count count="50"/>
        <page-count count="9"/>
        <word-count count="5989"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>Introduction</title>
      <p>Thyroid-associated ophthalmopathy (TAO) is an autoimmune orbital disorder which mainly targets adults of 30–50 years old (<xref rid="B1" ref-type="bibr">1</xref>). Although the pathogenesis of TAO is not yet entirely clear, the antigen shared by the thyroid gland and the orbit, primarily thyroid stimulating hormone receptor, may mediate the autoimmune response (<xref rid="B2" ref-type="bibr">2</xref>). Despite that TAO patients commonly complain about the ocular symptoms (<xref rid="B3" ref-type="bibr">3</xref>), the additional psychological and psychiatric disturbances can also markedly reduce the patients' quality of life (<xref rid="B4" ref-type="bibr">4</xref>). Specifically, cognitive function such as performing daily work and maintaining social relationships (<xref rid="B5" ref-type="bibr">5</xref>), and emotion regulation ability such as relieving depression and anxiety (<xref rid="B6" ref-type="bibr">6</xref>) have been reported to be impaired. A prior cohort study even showed a higher suicidal tendency for TAO patients (<xref rid="B7" ref-type="bibr">7</xref>). These evidences indicated that TAO might also be a neuropsychiatric disease, rather than merely orbital involvement (<xref rid="B8" ref-type="bibr">8</xref>).</p>
      <p>Recently, increasing researchers tried to use MRI techniques to explore the brain alterations in TAO patients. Structural neuroimaging studies have revealed both morphological and microstructural abnormalities corresponding to visual and cognitive deficits, and destruction of structural brain network connectome in TAO patients (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>). Meanwhile, several case-control studies have used functional neuroimaging methods, including amplitude of low-frequency fluctuation, regional homogeneity, and degree centrality, to evaluate the brain functional abnormality in TAO patients. They reported that TAO patients exhibited aberrant brain function involving default mode, visual, executive control, sensorimotor, and attention networks (<xref rid="B11" ref-type="bibr">11</xref>–<xref rid="B13" ref-type="bibr">13</xref>). However, the above-mentioned studies were only preliminary explorations using basic methods and were mainly concerned with functional segregation, which ignored the alterations of brain functional integration in TAO patients. Functional connectivity belongs to a useful measurement reflecting changes of brain functional integration (<xref rid="B14" ref-type="bibr">14</xref>), while it was seldom focused in studies on TAO. Until now, only one study reported the interhemispheric functional connectivity alterations of TAO using voxel-mirrored homotopic connectivity (<xref rid="B15" ref-type="bibr">15</xref>). However, it ignored the interregional and intraregional functional interactions of the brain. Inter-/intra- regional functional connectivity is suitable for reflecting widespread alterations in functional integration when deficits occur, and provides complementary information for a more targeted analysis (<xref rid="B16" ref-type="bibr">16</xref>). Besides, compared with other functional integration methods such as hypothesis-driven resting-state functional connectivity analysis, it can objectively and comprehensively reflect the abnormalities of functional connectivity within the whole-brain network (<xref rid="B17" ref-type="bibr">17</xref>).</p>
      <p>Functional connectivity density (FCD) analysis, a data-driven and graph-based approach, has been widely used in resting-state functional MRI (rs-fMRI) studies. It is mainly used to quantify global and local spontaneous neural activity. FCD is divided into long-range and short-range FCDs, reflecting interregional and intraregional functional interactions, respectively. Previously, the method has already been applied in several ocular diseases, such as glaucoma (<xref rid="B17" ref-type="bibr">17</xref>), neuromyelitis optica (<xref rid="B16" ref-type="bibr">16</xref>), corneal ulcer (<xref rid="B18" ref-type="bibr">18</xref>), and eye pain (<xref rid="B19" ref-type="bibr">19</xref>), to explore changes in global and local functional connectivity of the brain. Hence, we hypothesized that the underlying alterations of interregional and intraregional functional interactions in the TAO cohort could also be visualized by long- and short-range FCDs, which may be a supplement to the functional neural mechanism of TAO.</p>
      <p>Therefore, the purposes of our study were to (1) investigate underlying global and local spontaneous neural activity alterations using rs-fMRI with FCD analysis, and (2) relate the long- and short-range FCD values to the clinical parameters and scales in patients with TAO.</p>
    </sec>
    <sec sec-type="materials and methods" id="s2">
      <title>Materials and Methods</title>
      <sec>
        <title>Subjects</title>
        <p>Consecutively, 30 patients with TAO (18 females and 12 males, mean age 43.27 ± 14.20 years) were recruited from the department of endocrinology in our hospital. Concurrently, 30 healthy volunteers (18 females and 12 males, mean age 43.47 ± 13.62 years) were recruited from the local community, who were matched for age and gender with the patient group. All patients enrolled were in euthyroid status for at least 3 months (Reference ranges: serum free triiodothyronine, 3.10–6.80 pmol/L; free thyroxine, 12.00–22.00 pmol/L; thyroid-stimulating hormone, 0.270–4.200 mIU/L), in order to avoid the potential interference from thyroid hormone to the inner neural pattern of TAO. The exclusion criteria which were applied to all subjects were as follows: (1) local eye disorders caused by other reasons (amblyopia, strabismus, glaucoma, cataracts, etc.); (2) history of eye surgery; (3) history of neurological and psychiatric diseases (head injury, bipolar disorder, schizophrenia, etc.); (4) alcohol or drug addiction; (5) contraindications to MRI examination (implanted metal devices or cardiac pacemaker); (6) inadequate image quality. Comorbid depression and (or) anxiety symptoms were not regarded as exclusion criteria if TAO was the primary clinical diagnosis.</p>
      </sec>
      <sec>
        <title>Clinical Assessment</title>
        <p>Patients with TAO were clinically diagnosed by two experienced endocrinologists (with 17 and 35 years of experience in TAO assessment, respectively). The duration of TAO disease was defined from the onset of associated ophthalmic symptoms to the date of MRI examination. The scoring of disease activity was performed according to the modified 7-point clinical activity score (CAS) (<xref rid="B20" ref-type="bibr">20</xref>). Besides, the visual acuity and degree of exophthalmos were measured for each participant, and the values of the worse eye were recorded.</p>
        <p>Cognitive and psychometric assessments were conducted for each subject before the MRI scan. Hamilton Depression Rating Scale (HDRS) and Hamilton Anxiety Rating Scale (HARS) were used to assess the depressive symptoms and anxiety symptoms, respectively. Cognitive function was measured using Montreal Cognitive Assessment (MoCA). In addition, TAO-specific quality of life (QoL) questionnaire containing visual functioning and appearance was applied to each patient before the MRI scan (<xref rid="B21" ref-type="bibr">21</xref>).</p>
      </sec>
      <sec>
        <title>MRI Data Acquisition</title>
        <p>A 3.0-T MRI system (MAGNETOM Skyra; Siemens Healthcare, Erlangen, Germany) equipped with a 20-channel head coil was applied to acquire rs-fMRI data. Foam pads and earplugs were used to reduce head movement and scanning noise. Each participant was instructed to remain still in the supine position, with eyes closed and awake during the scan. An axial gradient echo planar imaging sequence was applied to acquire functional images with the following parameters: number of slices = 35, repetition time (TR) = 2,000 ms, echo time (TE) = 30 ms, flip angle = 90°, field of view (FOV) = 240 × 240 mm<sup>2</sup>, matrix = 64 × 64, thickness = 4.0 mm, and voxel size = 3.75 × 3.75 × 4 mm<sup>3</sup>. High-resolution sagittal structural T1-weighted images were also obtained with the following parameters: number of slices = 176, TR = 1,900 ms, TE = 2.45 ms, flip angle = 9°, FOV = 256 × 256 mm<sup>2</sup>, matrix = 256 × 256, thickness = 1.0 mm, and voxel size = 1 × 1 × 1 mm<sup>3</sup>. The total scanning duration was 12 min and 26 s.</p>
      </sec>
      <sec>
        <title>fMRI Data Preprocessing</title>
        <p>RESTplus V1.21 (<ext-link xlink:href="http://www.restfmri.net/forum/RESTplusV1.2" ext-link-type="uri">http://www.restfmri.net/forum/RESTplusV1.2</ext-link>) (<xref rid="B22" ref-type="bibr">22</xref>) was used to preprocess the rsfMRI data, which is based on SPM12 (<ext-link xlink:href="http://www.fil.ion.ucl.ac.uk/spm/software/spm12" ext-link-type="uri">http://www.fil.ion.ucl.ac.uk/spm/software/spm12</ext-link>) (<xref rid="B23" ref-type="bibr">23</xref>). The main processes were as follows: (1) the first ten volumes of each data were removed to reduce the influence of machine instability and subject adaptation to the environment; (2) slice timing correction was performed on the data of the remaining 230 time points; (3) realignment for head motion correction; (4) the realigned functional images were normalized to the Montreal Neurological Institute template by using T1 image unified segmentation; (5) and then the functional images were resampled to 3 × 3 × 3 mm<sup>3</sup> voxel; (6) detrending was conducted to remove linear trend; (7) the Friston 6-parameter model, cerebrospinal fluid, and white matter were regressed as covariates in MNI space; (8) bandpass filtering (based on frequency 0.01–0.08 Hz) was performed to reduce the effects of low frequency drift and high frequency noise. The whole dataset of this subject would be abandoned, if the maximum value of the head translation (rotation) movement was more than 2.0 mm (2.0°).</p>
      </sec>
      <sec>
        <title>Resting-State FCD Calculation</title>
        <p>Long- and short-range FCD calculations were performed using a Graph-theoretical Network Analysis Toolkit (GRETNA v1.2.1) (<ext-link xlink:href="http://www.nitrc.org/projects/gretna/" ext-link-type="uri">http://www.nitrc.org/projects/gretna/</ext-link>), which is based on the theory put forward by Tomasi and Volkow (<xref rid="B24" ref-type="bibr">24</xref>). In binary networks, FCD is defined as the number of functional connections for a given voxel, which is determined by setting a threshold to derive the Pearson's correlation coefficient of time-varying signals between one voxel and any other voxel. The correlation coefficient threshold (Tc) was set to 0.25 to keep a balance between false positive rate and sensitivity. In addition, if a correlation factor (<italic>r</italic>) &gt; 0.25, functional connectivity can be considered to exist (<xref rid="B25" ref-type="bibr">25</xref>). According to the study of He et al. (<xref rid="B26" ref-type="bibr">26</xref>), we classified functional connectivity into long- and short-range by a given anatomical distance of 75 mm. Short-range FCD was defined as the number of voxels that have functional connections to any voxel within the local area, while long-range FCD referred to the number of voxels that have functional connections to a voxel outside the local functional mass. Finally, Z-transformation was performed for the values of long- and short-range FCD maps to improve the normality of the distribution. Then, the Z-score transformed FCD data were spatially smoothed with a Gaussian kernel of 6 × 6 × 6 mm<sup>3</sup> depending on full width at half maximum (FWHM) to eliminate artifacts and increase the SNR.</p>
      </sec>
      <sec>
        <title>Statistical Analyses</title>
        <p>All clinical and demographic variables in our study were statistically analyzed using SPSS software (SPSS version 25.0, Inc., Chicago, IL, United States). For normally distributed variables, Student <italic>t-</italic>tests were employed to compare the differences between TAO and HC groups. For the non-parametric variables, Mann-Whitney <italic>U-</italic>tests were applied to analyze the differences between the two groups. Chi-square tests were used to analyze the differences of categorical data between the two groups. Statistical significance was set as <italic>p</italic> &lt; 0.05, with all tests being two-tailed.</p>
        <p>For the long- and short-range FCD values, statistical analyses were calculated by using SPM12. Independent two-sample <italic>t</italic>-tests were used to compare the differences of FCD values between TAO and HC groups with a gray-matter mask. Statistical significance was based on the current reporting guideline (<xref rid="B27" ref-type="bibr">27</xref>) to reduce the false positive rate, with a corrected threshold of voxel <italic>p</italic> &lt; 0.001, cluster <italic>p</italic> &lt; 0.05. With the peak voxels of significant brain regions in two-sample tests as spherical centers, spherical regions of interest (ROIs) (radius = 6 mm) of altered long- and short-range FCDs were created and extracted for each patient with TAO. Then, Pearson's and Spearman's correlation analyses were conducted to analyze the relationships between clinical data and FCD values within the group with TAO, with a statistical threshold of <italic>p</italic> &lt; 0.05.</p>
      </sec>
    </sec>
    <sec sec-type="results" id="s3">
      <title>Results</title>
      <sec>
        <title>Demographic and Clinical Data</title>
        <p>Demographic and clinical data of TAO and HC groups are presented in <xref rid="T1" ref-type="table">Table 1</xref>. Two groups were well matched for age (<italic>p</italic> = 0.956) and gender (<italic>p</italic> &gt; 0.999). Compared to HCs, patients with TAO showed significantly reduced visual acuity (<italic>p</italic> &lt; 0.001). Besides, patients with TAO scored higher in HARS (<italic>p</italic> &lt; 0.001) and HDRS (<italic>p</italic> &lt; 0.001), while lower in MoCA (<italic>p</italic> &lt; 0.001) than HCs.</p>
        <table-wrap position="float" id="T1">
          <label>Table 1</label>
          <caption>
            <p>Demographic and clinical characteristics of the group with TAO and HCs.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th valign="top" align="left" rowspan="1" colspan="1">
<bold>Items</bold>
</th>
                <th valign="top" align="center" rowspan="1" colspan="1">
<bold>TAO group (<italic>n</italic> = 30)</bold>
</th>
                <th valign="top" align="center" rowspan="1" colspan="1">
<bold>HCs (<italic>n</italic> = 30)</bold>
</th>
                <th valign="top" align="center" rowspan="1" colspan="1">
<bold><italic>p</italic>-value</bold>
</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Age (years)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">43.27 ± 14.20</td>
                <td valign="top" align="center" rowspan="1" colspan="1">43.47 ± 13.62</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.956</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Gender (female/male)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">18/12</td>
                <td valign="top" align="center" rowspan="1" colspan="1">18/12</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&gt;0.999</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Disease duration (months)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">10.03 ± 11.53</td>
                <td valign="top" align="center" rowspan="1" colspan="1">-</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">CAS</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3.17 ± 1.05</td>
                <td valign="top" align="center" rowspan="1" colspan="1">-</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">FT3 (pmol/L)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4.67 ± 0.76</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4.92 ± 0.96</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.337</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">FT4 (pmol/L)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">16.39 ± 2.83</td>
                <td valign="top" align="center" rowspan="1" colspan="1">16.80 ± 2.09</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.529</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">TSH (mIU/L)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.77 ± 1.83</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.63 ± 1.13</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.679</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Visual acuity</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.76 ± 0.15</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.97 ± 0.15</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Exophthalmos (mm)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">20.20 ± 3.57</td>
                <td valign="top" align="center" rowspan="1" colspan="1">-</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="4" rowspan="1">
<bold>QoL scores</bold>
</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Visual functioning</td>
                <td valign="top" align="center" rowspan="1" colspan="1">56.98 ± 31.36</td>
                <td valign="top" align="center" rowspan="1" colspan="1">-</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Appearance</td>
                <td valign="top" align="center" rowspan="1" colspan="1">65.60 ± 21.27</td>
                <td valign="top" align="center" rowspan="1" colspan="1">-</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Total score of HARS</td>
                <td valign="top" align="center" rowspan="1" colspan="1">17.13 ± 7.95</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2.50 ± 1.20</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Total score of HDRS</td>
                <td valign="top" align="center" rowspan="1" colspan="1">16.53 ± 6.95</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2.33 ± 1.67</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Total score of MoCA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">25.87 ± 3.35</td>
                <td valign="top" align="center" rowspan="1" colspan="1">28.77 ± 1.10</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p><italic>Data were presented as mean ± SD</italic>.</p>
            <p><italic>CAS, clinical activity score; FT3, free triiodothyronine; FT4, free thyroxine; TSH, thyroid-stimulating hormone; QoL, quality of life; HDRS, Hamilton Depression Rating Scale; HARS, Hamilton Anxiety Rating Scale; MoCA, Montreal Cognitive Assessment; TAO, thyroid-associated ophthalmopathy; HCs, healthy controls</italic>.</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>FCD Analysis</title>
        <p>In the group with TAO, the region of the left middle frontal gyrus (MFG), orbital part of superior frontal gyrus (ORBsup), and dorsolateral part of superior frontal gyrus (SFGdor) showed both significantly higher long- and short-range FCD values than in the HC group (<italic>p</italic> &lt; 0.05, cluster-level FWE corrected). Meanwhile, in the group with TAO, the region of bilateral postcentral gyrus (PoCG), left superior parietal gyrus (SPG), and inferior parietal (IPL) showed both significantly lower long- and short-range FCD values than in the HC group (<italic>p</italic> &lt; 0.05, cluster-level FWE corrected). In addition, only significantly increased short-range FCD in the right SFGdor, bilateral medial part of superior frontal gyrus (SFGmed), left orbital part of middle frontal gyrus (ORBmid), and orbital part of inferior frontal gyrus (ORBinf) (<italic>p</italic> &lt; 0.05, cluster-level FWE corrected), as well as decreased short-range FCD in the right supplementary motor area (SMA) and the left paracentral lobule (PCL), were observed in the group with TAO as compared to the HCs (<italic>p</italic> &lt; 0.05, cluster-level FWE corrected). The detailed information for all brain regions with significant long- and short-range FCDs between the two groups are presented in <xref rid="T2" ref-type="table">Table 2</xref> and <xref rid="F1" ref-type="fig">Figures 1</xref>, <xref rid="F2" ref-type="fig">2</xref>.</p>
        <table-wrap position="float" id="T2">
          <label>Table 2</label>
          <caption>
            <p>Brain areas with significantly different short- and long-range FCD values between groups (<italic>P</italic> &lt; 0.05, cluster-level FWE-corrected).</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th rowspan="1" colspan="1"/>
                <th rowspan="1" colspan="1"/>
                <th valign="top" align="center" style="border-bottom: thin solid #000000;" colspan="3" rowspan="1">
<bold>MNI coordinates</bold>
</th>
                <th rowspan="1" colspan="1"/>
                <th rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <th valign="top" align="left" rowspan="1" colspan="1">
<bold>Brain regions/conditions</bold>
</th>
                <th valign="top" align="center" rowspan="1" colspan="1">
<bold>BA</bold>
</th>
                <th valign="top" align="center" rowspan="1" colspan="1">
<bold>X</bold>
</th>
                <th valign="top" align="center" rowspan="1" colspan="1">
<bold>Y</bold>
</th>
                <th valign="top" align="center" rowspan="1" colspan="1">
<bold>Z</bold>
</th>
                <th valign="top" align="center" rowspan="1" colspan="1">
<bold>Cluster size (number of voxels)</bold>
</th>
                <th valign="top" align="center" rowspan="1" colspan="1">
<bold><italic>t</italic>-value</bold>
</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td valign="top" align="left" colspan="7" rowspan="1">
<bold>Short-range FCD:</bold>
</td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="7" rowspan="1"><bold>TAO group</bold>
<bold>&gt;</bold>
<bold>HCs</bold></td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">SFGdor.L/R,</td>
                <td valign="top" align="center" rowspan="1" colspan="1">9/10/11/46/47</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−24</td>
                <td valign="top" align="center" rowspan="1" colspan="1">57</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1,140</td>
                <td valign="top" align="center" rowspan="1" colspan="1">5.746</td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="7" rowspan="1">MFG.L,</td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="7" rowspan="1">SFGmed.L/R,</td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="7" rowspan="1">ORBmid.L,</td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="7" rowspan="1">ORBinf.L,</td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="7" rowspan="1">ORBsup.L</td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="7" rowspan="1"><bold>TAO group</bold>
<bold>&lt;</bold>
<bold>HCs</bold></td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">PoCG.L, SPG.L, IPL.L</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2/3</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−45</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−27</td>
                <td valign="top" align="center" rowspan="1" colspan="1">48</td>
                <td valign="top" align="center" rowspan="1" colspan="1">482</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−6.057</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">PoCG.R</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3</td>
                <td valign="top" align="center" rowspan="1" colspan="1">39</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−33</td>
                <td valign="top" align="center" rowspan="1" colspan="1">57</td>
                <td valign="top" align="center" rowspan="1" colspan="1">130</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−4.400</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">SMA.R, PCL.L</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4/6</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−3</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−21</td>
                <td valign="top" align="center" rowspan="1" colspan="1">60</td>
                <td valign="top" align="center" rowspan="1" colspan="1">109</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−4.466</td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="7" rowspan="1">
<bold>Long-range FCD:</bold>
</td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="7" rowspan="1"><bold>TAO group</bold>
<bold>&gt;</bold>
<bold>HCs</bold></td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">MFG.L, ORBsup.L, SFGdor.L</td>
                <td valign="top" align="center" rowspan="1" colspan="1">10/11/46/47</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−24</td>
                <td valign="top" align="center" rowspan="1" colspan="1">57</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−3</td>
                <td valign="top" align="center" rowspan="1" colspan="1">114</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4.759</td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="7" rowspan="1"><bold>TAO group</bold>
<bold>&lt;</bold>
<bold>HCs</bold></td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">PoCG.L, SPG.L, IPL.L</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2/3</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−45</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−27</td>
                <td valign="top" align="center" rowspan="1" colspan="1">48</td>
                <td valign="top" align="center" rowspan="1" colspan="1">482</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−6.057</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">PoCG.R</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3</td>
                <td valign="top" align="center" rowspan="1" colspan="1">39</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−30</td>
                <td valign="top" align="center" rowspan="1" colspan="1">54</td>
                <td valign="top" align="center" rowspan="1" colspan="1">234</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−4.589</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p><italic>FCD, Functional connectivity density; FWE, family-wise error; BA, Brodmann's areas; MNI, Montreal Neurologic Institute; TAO, thyroid associated ophthalmopathy; HCs, healthy controls; R, right; L, left; SFGdor, dorsolateral part of superior frontal gyrus; MFG, middle frontal gyrus; SFGmed, medial part of superior frontal gyrus; ORBmid, orbital part of middle frontal gyrus; ORBinf, orbital part of Inferior frontal gyrus; ORBsup, orbital part of superior frontal gyrus; PoCG, postcentral gyrus; SPG, superior parietal gyrus; IPL, inferior parietal; SMA, supplementary motor area; PCL, paracentral lobule</italic>.</p>
          </table-wrap-foot>
        </table-wrap>
        <fig position="float" id="F1">
          <label>Figure 1</label>
          <caption>
            <p>Brain regions with short-range FCD difference between the group with TAO and HCs. Compared with HCs, the group with TAO showed significantly increased short-range FCD in the bilateral SFGdor and SFGmed, left MFG, ORBmid, ORBinf, and ORBsup, and significantly decreased short-range FCD in the bilateral PoCG, left SPG, IPL, PCL, and right SMA (voxel <italic>p</italic> &lt; 0.001, cluster <italic>p</italic> &lt; 0.05, cluster-level FWE corrected, cluster size ≥ 109 voxels). The color bar indicates the <italic>T-</italic>value from two-sample <italic>t-</italic>tests between the group with TAO and HCs, the warm color denotes relatively higher short-range FCD in the group with TAO, and the cold color denotes relatively lower short-range FCD in the group with TAO. FCD, Functional connectivity density; SFGdor, dorsolateral part of superior frontal gyrus; SFGmed, medial part of superior frontal gyrus; MFG, middle frontal gyrus; ORBmid, orbital part of middle frontal gyrus; ORBinf, orbital part of Inferior frontal gyrus; ORBsup, orbital part of superior frontal gyrus; PoCG, postcentral gyrus; SPG, Superior parietal gyrus; IPL, Inferior parietal; PCL, paracentral lobule; SMA, supplementary motor area; FWE, family-wise error.</p>
          </caption>
          <graphic xlink:href="fneur-13-902912-g0001" position="float"/>
        </fig>
        <fig position="float" id="F2">
          <label>Figure 2</label>
          <caption>
            <p>Brain regions with long-range FCD difference between the group with TAO and HCs. Compared with HCs, the group with TAO showed significantly increased long-range FCD in the left MFG, ORBsup, and SFGdor, and significantly decreased long-range FCD in the bilateral PoCG, left SPG, and IPL (voxel <italic>p</italic> &lt; 0.001, cluster <italic>p</italic> &lt; 0.05, cluster-level FWE corrected, cluster size ≥ 114 voxels). The color bar indicates the T value from two-sample <italic>t-</italic>tests between the group with TAO and HCs, the warm color denotes relatively higher long-range FCD in the group with TAO, and the cold color denotes relatively lower long-range FCD in the group with TAO. FCD, Functional connectivity density; MFG, middle frontal gyrus; ORBsup, orbital part of superior frontal gyrus; SFGdor, dorsolateral part of superior frontal gyrus; PoCG, Postcentral gyrus; SPG, Superior parietal gyrus; IPL, Inferior parietal; FWE, family-wise error.</p>
          </caption>
          <graphic xlink:href="fneur-13-902912-g0002" position="float"/>
        </fig>
      </sec>
      <sec>
        <title>Correlation Analysis</title>
        <p>In the group with TAO, short-range FCD value in the left SFGdor was negatively correlated with the MoCA score (<italic>r</italic> = −0.501, <italic>p</italic> = 0.005) (<xref rid="F3" ref-type="fig">Figure 3</xref>). No significant correlation was found between the FCD values and any other clinical measures (<italic>p</italic> &gt; 0.05).</p>
        <fig position="float" id="F3">
          <label>Figure 3</label>
          <caption>
            <p>Scatter diagram showing the significant correlation between clinical index and short-range FCD value in the SFGdor in the group with TAO. Short-range FCD value was negatively correlated with the MoCA score (<italic>r</italic> = −0.501, <italic>p</italic> = 0.005). FCD, Functional connectivity density; SFGdor, dorsolateral part of superior frontal gyrus.</p>
          </caption>
          <graphic xlink:href="fneur-13-902912-g0003" position="float"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="discussion" id="s4">
      <title>Discussion</title>
      <p>In this study, the group with TAO demonstrated increased short-range FCD values in the bilateral SFGdor and SFGmed, and left MFG, ORBmid, ORBinf and ORBsup, as well as increased long-range FCD values in the left MFG, ORBsup, and SFGdor compared with the HC group. The involved brain regions are all important components of the prefrontal cortex, which is generally considered to be associated with cognitive function (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>). Previous rsfMRI studies regarding aging associated disorders, including Alzheimer's disease, Parkinsonism, frontotemporal dementia, and post-ischemic stroke, have reported aberrant functional connectivity in the prefrontal cortex (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>). Aging associated disorders are usually accompanied by cognitive dysfunction, and the prefrontal cortex is thought to perform top-down control by connecting other brain regions to enable complex cognitive processes (<xref rid="B32" ref-type="bibr">32</xref>). Therefore, the altered long- and short-range FCDs of the patient group in this study may also indicate the cognitive impairment related with TAO. Besides, as a part of the cognition functions, social cognition requires the integration of multiple behaviors, including reward-seeking, salience, motivation, and knowledge of self and others, which are also conducted by the prefrontal cortex (<xref rid="B33" ref-type="bibr">33</xref>). Patients with TAO were reported to occasionally present with social barriers due to altered appearance or other complicated factors (<xref rid="B34" ref-type="bibr">34</xref>), which may also contribute to the abnormal functional connectivity of the prefrontal cortex.</p>
      <p>However, interestingly, both the long- and short-range FCDs of prefrontal cortex were increased in the group with TAO, but not the expected decreased values. Coincidentally, one study using the method of regional homogeneity also reported increased value of the prefrontal cortex in TAO (<xref rid="B13" ref-type="bibr">13</xref>). Hence, as reference to prior knowledge, the currently increased FCD values might be regarded as a compensatory mechanism in the brain owing to cognitive impairment (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B35" ref-type="bibr">35</xref>). The negative correlation between the FCD value and MoCA score could further help verify the above deduction, and suggest that the compensatory changes in the prefrontal cortex may progress with cognitive decline.</p>
      <p>Another significant finding of our study was the reduction of both long- and short-range FCDs in bilateral PoCG and left SPG and IPL in the group with TAO. The PoCG and SPG participate in the formation of dorsal visual pathway, which is responsible for processing spatial information (<xref rid="B17" ref-type="bibr">17</xref>). In recent years, several rs-fMRI studies focusing on other orbital diseases (e.g., glaucoma, exotropia, and blindness) have demonstrated decreased functional connectivity in the PoCG (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B37" ref-type="bibr">37</xref>). As for the IPL, Nardella et al. (<xref rid="B38" ref-type="bibr">38</xref>) suggested that this region was involved in encoding visual temporal resolution by changing the critical flicker frequency threshold. Taken together, the currently reduced FCD values in these regions could also correspond to the visual impairment in TAO. In addition, PoCG is also thought to be involved in the encoding of pain and touch due to its location in the primary sensory cortex, which is essential for sensory functions (<xref rid="B39" ref-type="bibr">39</xref>). Considering that the ocular discomforts such as conjunctival hyperemia and eyelid edema commonly occur in TAO patients, we speculated that these somatosensory symptoms may partially relate to the altered functional connectivity in the PoCG.</p>
      <p>In addition, the group with TAO showed a decreased short-range FCD in the right SMA and left PCL, compared with the HCs. SMA is located anterior to the primary motor cortex, playing an important role in digital cognition, sports, space and time processing, language and music processing, and working memory (<xref rid="B40" ref-type="bibr">40</xref>). Previous studies suggested that SMA is a key hub for depressive episodes in Parkinson's disease (<xref rid="B41" ref-type="bibr">41</xref>), and significantly decreased glucose metabolism in SMA is one of the characteristics of patients with refractory depression (<xref rid="B42" ref-type="bibr">42</xref>). Besides that, a systematic review reported that transcranial direct current stimulation of the SMA can relieve anxiety symptoms of patients with obsessive-compulsive disorder (<xref rid="B43" ref-type="bibr">43</xref>). PCL has bidirectional connections with precuneus (<xref rid="B44" ref-type="bibr">44</xref>), which is an important component of default mode network associated with mood disorder (<xref rid="B45" ref-type="bibr">45</xref>). Lots of research have shown structural and functional alterations in the PCL of depression and depression-related disorders (<xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B47" ref-type="bibr">47</xref>). Therefore, combing the elevated HARS and HDRS scores in the patient group, the reduction of local functional connectivity in SMA and PCL may also be associated with the emotional disturbance in patients with TAO.</p>
      <p>Summarizing all the results, our study had the following interesting findings: First, there were many overlap results observed between long- and short-range FCDs. Similar results have been reported in previous rs-fMRI researches using FCD analysis regarding other diseases (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B19" ref-type="bibr">19</xref>). These results might be due to the fact that long- and short-range FCDs are not completely independent, but interrelated (<xref rid="B48" ref-type="bibr">48</xref>). Deco et al. (<xref rid="B49" ref-type="bibr">49</xref>) has shown that the functional property of local (short-range) connectivity can influence remote (long-range) connectivity through feedback inhibition. Second, short-range FCD results were more abundant than long-range FCD results between TAO and HC groups. Short-range FCD is deemed to be more sensitive than long-range FCD to localize the functional organization with more alterations in local brain regions (<xref rid="B50" ref-type="bibr">50</xref>). Therefore, it is reasonable that more brain regions with altered functional connectivity were visualized using short-range metric. Nonetheless, through investigating the alterations of both interregional and intraregional functional interactions, this study revealed the intrinsic brain activity abnormalities mainly associated with cognitive, visual, and emotional dysfunctions in patients with TAO. Our findings might provide a new supplementary insight to the underlying neural basis of TAO disease.</p>
      <p>This study has several limitations. First, this was a cross-sectional study. Longitudinal studies are needed to elucidate the process of functional connectivity changes and their relationships with clinical variables in the future. Second, although patients with TAO and short-term euthyroid status were recruited in this study, the potential effects of thyroid hormones on brain functional alterations cannot be fully circumvented. Future research by adding primarily patients with euthyroid TAO is warranted to verify our findings.</p>
      <p>In conclusion, patients with TAO showed altered long- and short-range FCDs in the prefrontal cortex and parietal lobe, indicating potential cognitive, visual, and emotional dysfunctions. Our findings provided promising neuroimaging markers for assessing the psychiatric, visual, and emotional disturbances in patients with TAO.</p>
    </sec>
    <sec sec-type="data-availability" id="s5">
      <title>Data Availability Statement</title>
      <p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
    </sec>
    <sec id="s6">
      <title>Ethics Statement</title>
      <p>The studies involving human participants were reviewed and approved by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University. The patients/participants provided their written informed consent to participate in this study.</p>
    </sec>
    <sec id="s7">
      <title>Author Contributions</title>
      <p>H-HC, X-QX, and F-YW conceptualized and designed the study. W-HJ, WC, QW, LC, and JZ performed the MR scan. W-HJ performed the MR data analyses and wrote the first draft. H-HC contributed to the diagnosis and clinical data collection. HH provided critical revisions of the draft. All authors approved the manuscript for submission. All authors contributed to the article and approved the submitted version.</p>
    </sec>
    <sec sec-type="funding-information" id="s8">
      <title>Funding</title>
      <p>This work was supported by the National Natural Science Foundation of China (NSFC) (81801659 to HH) and Clinical Capability Promotion Project of Jiangsu Province Hospital (to X-QX).</p>
    </sec>
    <sec sec-type="COI-statement" id="conf1">
      <title>Conflict of Interest</title>
      <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
    </sec>
    <sec sec-type="disclaimer" id="s9">
      <title>Publisher's Note</title>
      <p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartalena</surname><given-names>L</given-names></name><name><surname>Marcocci</surname><given-names>C</given-names></name><name><surname>Pinchera</surname><given-names>A</given-names></name></person-group>. <article-title>Graves' ophthalmopathy: a preventable disease?</article-title>
<source>Eur J Endocrinol.</source> (<year>2002</year>) <volume>146</volume>:<fpage>457</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1530/eje.0.1460457</pub-id><pub-id pub-id-type="pmid">11916611</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiromatsu</surname><given-names>Y</given-names></name><name><surname>Eguchi</surname><given-names>H</given-names></name><name><surname>Tani</surname><given-names>J</given-names></name><name><surname>Kasaoka</surname><given-names>M</given-names></name><name><surname>Teshima</surname><given-names>Y</given-names></name></person-group>. <article-title>Graves' ophthalmopathy: epidemiology and natural history</article-title>. <source>Intern Med.</source> (<year>2014</year>) <volume>53</volume>:<fpage>353</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.2169/internalmedicine.53.1518</pub-id><pub-id pub-id-type="pmid">24583420</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahli</surname><given-names>E</given-names></name><name><surname>Gündüz</surname><given-names>K</given-names></name></person-group>. <article-title>Thyroid-associated ophthalmopathy</article-title>. <source>Turk J Ophthalmol.</source> (<year>2017</year>) <volume>47</volume>:<fpage>94</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.4274/tjo.80688</pub-id><pub-id pub-id-type="pmid">28405484</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Roh</surname><given-names>HS</given-names></name><name><surname>Yoon</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>SY</given-names></name></person-group>. <article-title>Assessment of quality of life and depression in Korean patients with Graves' ophthalmopathy</article-title>. <source>Korean J Ophthalmol.</source> (<year>2010</year>) <volume>24</volume>:<fpage>65</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.3341/kjo.2010.24.2.65</pub-id><pub-id pub-id-type="pmid">20379454</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>AL</given-names></name><name><surname>Harder</surname><given-names>I</given-names></name></person-group>. <article-title>The impact of bodily change on social behaviour in patients with thyroid-associated ophthalmopathy</article-title>. <source>Scand J Caring Sci.</source> (<year>2011</year>) <volume>25</volume>:<fpage>341</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-6712.2010.00832.x</pub-id><pub-id pub-id-type="pmid">21564149</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cockerham</surname><given-names>KP</given-names></name><name><surname>Padnick-Silver</surname><given-names>L</given-names></name><name><surname>Stuertz</surname><given-names>N</given-names></name><name><surname>Francis-Sedlak</surname><given-names>M</given-names></name><name><surname>Holt</surname><given-names>RJ</given-names></name></person-group>. <article-title>Quality of life in patients with chronic thyroid eye disease in the United States</article-title>. <source>Ophthalmol Ther.</source> (<year>2021</year>) <volume>10</volume>:<fpage>975</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1007/s40123-021-00385-8</pub-id><pub-id pub-id-type="pmid">34478126</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferløv-Schwensen</surname><given-names>C</given-names></name><name><surname>Brix</surname><given-names>TH</given-names></name><name><surname>Hegedüs</surname><given-names>L</given-names></name></person-group>. <article-title>Death by suicide in graves' disease and graves' orbitopathy: a nationwide danish register study</article-title>. <source>Thyroid.</source> (<year>2017</year>) <volume>27</volume>:<fpage>1475</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1089/thy.2017.0365</pub-id><pub-id pub-id-type="pmid">29084476</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riguetto</surname><given-names>CM</given-names></name><name><surname>Neto</surname><given-names>AM</given-names></name><name><surname>Tambascia</surname><given-names>MA</given-names></name><name><surname>Zantut-Wittmann</surname><given-names>DE</given-names></name></person-group>. <article-title>The relationship between quality of life, cognition, and thyroid status in Graves' disease</article-title>. <source>Endocrine.</source> (<year>2019</year>) <volume>63</volume>:<fpage>87</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1007/s12020-018-1733-y</pub-id><pub-id pub-id-type="pmid">30173328</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>HH</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>XQ</given-names></name><etal/></person-group>. <article-title>Morphological and microstructural brain changes in thyroid-associated ophthalmopathy: a combined voxel-based morphometry and diffusion tensor imaging study</article-title>. <source>J Endocrinol Invest.</source> (<year>2020</year>) <volume>43</volume>:<fpage>1591</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s40618-020-01242-4</pub-id><pub-id pub-id-type="pmid">32253727</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>HH</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Disrupted topological organization of the brain structural network in patients with thyroid-associated ophthalmopathy</article-title>. <source>Invest Ophthalmol Vis Sci.</source> (<year>2021</year>) <volume>62</volume>:<fpage>5</fpage>. <pub-id pub-id-type="doi">10.1167/iovs.62.4.5</pub-id><pub-id pub-id-type="pmid">33821882</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tu</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>P</given-names></name><name><surname>Mao</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name></person-group>. <article-title>Abnormal functional connectivity density in patients with dysthyroid optic neuropathy</article-title>. <source>Ophthalmic Res</source>. (<year>2022</year>) <volume>65</volume>:<fpage>171</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1159/000512755</pub-id><pub-id pub-id-type="pmid">33142292</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>HH</given-names></name><name><surname>Xu</surname><given-names>XQ</given-names></name><etal/></person-group>. <article-title>Disrupted spontaneous neural activity in patients with thyroid-associated ophthalmopathy: a resting-state fMRI study using amplitude of low-frequency fluctuation</article-title>. <source>Front Hum Neurosci.</source> (<year>2021</year>) <volume>15</volume>:<fpage>676967</fpage>. <pub-id pub-id-type="doi">10.3389/fnhum.2021.676967</pub-id><pub-id pub-id-type="pmid">34177495</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>HH</given-names></name><name><surname>Xu</surname><given-names>XQ</given-names></name><etal/></person-group>. <article-title>Aberrant brain voxel-wise resting state fMRI in patients with thyroid-associated ophthalmopathy</article-title>. <source>J Neuroimaging.</source> (<year>2021</year>) <volume>31</volume>:<fpage>773</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1111/jon.12858</pub-id><pub-id pub-id-type="pmid">33817897</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Biswal</surname><given-names>BB</given-names></name><name><surname>Han</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Altered dynamics of brain segregation and integration in poststroke aphasia</article-title>. <source>Hum Brain Mapp.</source> (<year>2019</year>) <volume>40</volume>:<fpage>3398</fpage>–<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1002/hbm.24605</pub-id><pub-id pub-id-type="pmid">31016854</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>HH</given-names></name><etal/></person-group>. <article-title>Altered static and dynamic interhemispheric resting-state functional connectivity in patients with thyroid-associated ophthalmopathy</article-title>. <source>Front Neurosci.</source> (<year>2021</year>) <volume>15</volume>:<fpage>799916</fpage>. <pub-id pub-id-type="doi">10.3389/fnins.2021.799916</pub-id><pub-id pub-id-type="pmid">34938158</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Kwapong</surname><given-names>WR</given-names></name><name><surname>Tu</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>J</given-names></name><name><surname>Miao</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Altered resting-state functional connectivity density in patients with neuromyelitis optica-spectrum disorders</article-title>. <source>Mult Scler Relat Disord.</source> (<year>2020</year>) <volume>43</volume>:<fpage>102187</fpage>. <pub-id pub-id-type="doi">10.1016/j.msard.2020.102187</pub-id><pub-id pub-id-type="pmid">32480345</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Cai</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Gong</surname><given-names>H</given-names></name><name><surname>Pei</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Altered functional connectivity density in primary angle-closure glaucoma patients at resting-state</article-title>. <source>Quant Imaging Med Surg.</source> (<year>2019</year>) <volume>9</volume>:<fpage>603</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.21037/qims.2019.04.13</pub-id><pub-id pub-id-type="pmid">31143651</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>F</given-names></name><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>P</given-names></name><name><surname>Lin</surname><given-names>Q</given-names></name><name><surname>Yuan</surname><given-names>Q</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Resting-state functional magnetic resonance imaging (fMRI) and functional connectivity density mapping in patients with corneal ulcer</article-title>. <source>Neuropsychiatr Dis Treat.</source> (<year>2019</year>) <volume>15</volume>:<fpage>1833</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.2147/NDT.S210658</pub-id><pub-id pub-id-type="pmid">31308676</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>PW</given-names></name><name><surname>Shi</surname><given-names>WQ</given-names></name><name><surname>Min</surname><given-names>YL</given-names></name><name><surname>Lin</surname><given-names>Q</given-names></name><name><surname>Ge</surname><given-names>QM</given-names></name><etal/></person-group>. <article-title>Resting-state functional MRI study demonstrates that the density of functional connectivity density mapping changes in patients with acute eye pain</article-title>. <source>J Pain Res.</source> (<year>2020</year>) <volume>13</volume>:<fpage>2103</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.2147/JPR.S224687</pub-id><pub-id pub-id-type="pmid">32982384</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartalena</surname><given-names>L</given-names></name><name><surname>Baldeschi</surname><given-names>L</given-names></name><name><surname>Boboridis</surname><given-names>K</given-names></name><name><surname>Eckstein</surname><given-names>A</given-names></name><name><surname>Kahaly</surname><given-names>GJ</given-names></name><name><surname>Marcocci</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>The 2016 European thyroid association/European group on graves' orbitopathy guidelines for the management of graves' orbitopathy</article-title>. <source>Eur Thyroid J.</source> (<year>2016</year>) <volume>5</volume>:<fpage>9</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1159/000443828</pub-id><pub-id pub-id-type="pmid">27099835</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>IC</given-names></name><name><surname>Lee</surname><given-names>CC</given-names></name><name><surname>Liao</surname><given-names>SL</given-names></name></person-group>. <article-title>Assessing quality of life in Taiwanese patients with Graves' ophthalmopathy</article-title>. <source>J Formos Med Assoc.</source> (<year>2015</year>) <volume>114</volume>:<fpage>1047</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.jfma.2013.12.002</pub-id><pub-id pub-id-type="pmid">24434244</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>XW</given-names></name><name><surname>Dong</surname><given-names>ZY</given-names></name><name><surname>Long</surname><given-names>XY</given-names></name><name><surname>Li</surname><given-names>SF</given-names></name><name><surname>Zuo</surname><given-names>XN</given-names></name><name><surname>Zhu</surname><given-names>CZ</given-names></name><etal/></person-group>. <article-title>REST: a toolkit for resting-state functional magnetic resonance imaging data processing</article-title>. <source>PLoS ONE.</source> (<year>2011</year>) <volume>6</volume>:<fpage>e25031</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0025031</pub-id><pub-id pub-id-type="pmid">21949842</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashburner</surname><given-names>J</given-names></name></person-group>. <article-title>SPM: a history</article-title>. <source>Neuroimage.</source> (<year>2012</year>) <volume>62</volume>:<fpage>791</fpage>–<lpage>800</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.10.025</pub-id><pub-id pub-id-type="pmid">22023741</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <label>24.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomasi</surname><given-names>D</given-names></name><name><surname>Volkow</surname><given-names>ND</given-names></name></person-group>. <article-title>Association between functional connectivity hubs and brain networks</article-title>. <source>Cereb Cortex.</source> (<year>2011</year>) <volume>21</volume>:<fpage>2003</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhq268</pub-id><pub-id pub-id-type="pmid">21282318</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckner</surname><given-names>RL</given-names></name><name><surname>Sepulcre</surname><given-names>J</given-names></name><name><surname>Talukdar</surname><given-names>T</given-names></name><name><surname>Krienen</surname><given-names>FM</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Hedden</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease</article-title>. <source>J Neurosci.</source> (<year>2009</year>) <volume>29</volume>:<fpage>1860</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5062-08.2009</pub-id><pub-id pub-id-type="pmid">19211893</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <label>26.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>ZJ</given-names></name><name><surname>Evans</surname><given-names>AC</given-names></name></person-group>. <article-title>Small-world anatomical networks in the human brain revealed by cortical thickness from MRI</article-title>. <source>Cereb Cortex.</source> (<year>2007</year>) <volume>17</volume>:<fpage>2407</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhl149</pub-id><pub-id pub-id-type="pmid">17204824</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eklund</surname><given-names>A</given-names></name><name><surname>Nichols</surname><given-names>TE</given-names></name><name><surname>Knutsson</surname><given-names>H</given-names></name></person-group>. <article-title>Cluster failure: why fMRI inferences for spatial extent have inflated false-positive rates</article-title>. <source>Proc Natl Acad Sci U S A.</source> (<year>2016</year>) <volume>113</volume>:<fpage>7900</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1602413113</pub-id><pub-id pub-id-type="pmid">27357684</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <label>28.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnsten</surname><given-names>AF</given-names></name></person-group>. <article-title>Stress weakens prefrontal networks: molecular insults to higher cognition</article-title>. <source>Nat Neurosci.</source> (<year>2015</year>) <volume>18</volume>:<fpage>1376</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4087</pub-id><pub-id pub-id-type="pmid">26404712</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <label>29.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parnaudeau</surname><given-names>S</given-names></name><name><surname>Bolkan</surname><given-names>SS</given-names></name><name><surname>Kellendonk</surname><given-names>C</given-names></name></person-group>. <article-title>The mediodorsal thalamus: an essential partner of the prefrontal cortex for cognition</article-title>. <source>Biol Psychiatry.</source> (<year>2018</year>) <volume>83</volume>:<fpage>648</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2017.11.008</pub-id><pub-id pub-id-type="pmid">29275841</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <label>30.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caminiti</surname><given-names>SP</given-names></name><name><surname>Canessa</surname><given-names>N</given-names></name><name><surname>Cerami</surname><given-names>C</given-names></name><name><surname>Dodich</surname><given-names>A</given-names></name><name><surname>Crespi</surname><given-names>C</given-names></name><name><surname>Iannaccone</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Affective mentalizing and brain activity at rest in the behavioral variant of frontotemporal dementia</article-title>. <source>Neuroimage Clin.</source> (<year>2015</year>) <volume>9</volume>:<fpage>484</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/j.nicl.2015.08.012</pub-id><pub-id pub-id-type="pmid">26594631</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <label>31.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghahremani</surname><given-names>M</given-names></name><name><surname>Yoo</surname><given-names>J</given-names></name><name><surname>Chung</surname><given-names>SJ</given-names></name><name><surname>Yoo</surname><given-names>K</given-names></name><name><surname>Ye</surname><given-names>JC</given-names></name><name><surname>Jeong</surname><given-names>Y</given-names></name></person-group>. <article-title>Alteration in the local and global functional connectivity of resting state networks in Parkinson's disease</article-title>. <source>J Mov Disord.</source> (<year>2018</year>) <volume>11</volume>:<fpage>13</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.14802/jmd.17061</pub-id><pub-id pub-id-type="pmid">29381889</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <label>32.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jobson</surname><given-names>DD</given-names></name><name><surname>Hase</surname><given-names>Y</given-names></name><name><surname>Clarkson</surname><given-names>AN</given-names></name><name><surname>Kalaria</surname><given-names>RN</given-names></name></person-group>. <article-title>The role of the medial prefrontal cortex in cognition, ageing and dementia</article-title>. <source>Brain Commun</source>. (<year>2021</year>) <volume>3</volume>:<fpage>fcab125</fpage>. <pub-id pub-id-type="doi">10.1093/braincomms/fcab125</pub-id><pub-id pub-id-type="pmid">34222873</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <label>33.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiser</surname><given-names>J</given-names></name><name><surname>Koenigs</surname><given-names>M</given-names></name></person-group>. <article-title>The multifaceted role of the ventromedial prefrontal cortex in emotion, decision making, social cognition, and psychopathology</article-title>. <source>Biol Psychiatry.</source> (<year>2018</year>) <volume>83</volume>:<fpage>638</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2017.10.030</pub-id><pub-id pub-id-type="pmid">29275839</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <label>34.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>P</given-names></name><name><surname>Fan</surname><given-names>SX</given-names></name><name><surname>Li</surname><given-names>ZJ</given-names></name><name><surname>Peng</surname><given-names>YY</given-names></name><name><surname>Hu</surname><given-names>YX</given-names></name><name><surname>Xu</surname><given-names>MT</given-names></name><etal/></person-group>. <article-title>Evaluation of the graves' orbitopathy-specific quality of life questionnaire in the mainland Chinese population</article-title>. <source>J Ophthalmol.</source> (<year>2019</year>) <volume>2019</volume>:<fpage>7602419</fpage>. <pub-id pub-id-type="doi">10.1155/2019/7602419</pub-id><pub-id pub-id-type="pmid">31011452</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <label>35.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>QH</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>XM</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>JH</given-names></name></person-group>. <article-title>Differential regional brain spontaneous activity in subgroups of mild cognitive impairment</article-title>. <source>Front Hum Neurosci.</source> (<year>2020</year>) <volume>14</volume>:<fpage>2</fpage>. <pub-id pub-id-type="doi">10.3389/fnhum.2020.00002</pub-id><pub-id pub-id-type="pmid">32082131</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <label>36.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>W</given-names></name><name><surname>Xuan</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name></person-group>. <article-title>Functional connectivity density in congenitally and late blind subjects</article-title>. <source>Cereb Cortex.</source> (<year>2015</year>) <volume>25</volume>:<fpage>2507</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhu051</pub-id><pub-id pub-id-type="pmid">24642421</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <label>37.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>X</given-names></name><name><surname>Hong</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Qu</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Altered spontaneous brain activity patterns and functional connectivity in adults with intermittent exotropia: a resting-state fMRI study</article-title>. <source>Front Neurosci.</source> (<year>2021</year>) <volume>15</volume>:<fpage>746882</fpage>. <pub-id pub-id-type="doi">10.3389/fnins.2021.746882</pub-id><pub-id pub-id-type="pmid">34776850</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <label>38.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nardella</surname><given-names>A</given-names></name><name><surname>Rocchi</surname><given-names>L</given-names></name><name><surname>Conte</surname><given-names>A</given-names></name><name><surname>Bologna</surname><given-names>M</given-names></name><name><surname>Suppa</surname><given-names>A</given-names></name><name><surname>Berardelli</surname><given-names>A</given-names></name></person-group>. <article-title>Inferior parietal lobule encodes visual temporal resolution processes contributing to the critical flicker frequency threshold in humans</article-title>. <source>PLoS ONE.</source> (<year>2014</year>) <volume>9</volume>:<fpage>e98948</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0098948</pub-id><pub-id pub-id-type="pmid">24905987</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <label>39.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gazzola</surname><given-names>V</given-names></name><name><surname>Spezio</surname><given-names>ML</given-names></name><name><surname>Etzel</surname><given-names>JA</given-names></name><name><surname>Castelli</surname><given-names>F</given-names></name><name><surname>Adolphs</surname><given-names>R</given-names></name><name><surname>Keysers</surname><given-names>C</given-names></name></person-group>. <article-title>Primary somatosensory cortex discriminates affective significance in social touch</article-title>. <source>Proc Natl Acad Sci U S A.</source> (<year>2012</year>) <volume>109</volume>:<fpage>E1657</fpage>–<lpage>1666</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1113211109</pub-id><pub-id pub-id-type="pmid">22665808</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <label>40.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cona</surname><given-names>G</given-names></name><name><surname>Semenza</surname><given-names>C</given-names></name></person-group>. <article-title>Supplementary motor area as key structure for domain-general sequence processing: a unified account</article-title>. <source>Neurosci Biobehav Rev.</source> (<year>2017</year>) <volume>72</volume>:<fpage>28</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2016.10.033</pub-id><pub-id pub-id-type="pmid">27856331</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <label>41.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>H</given-names></name><name><surname>Yi</surname><given-names>J</given-names></name><name><surname>Cai</surname><given-names>S</given-names></name><name><surname>Shen</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Changes in degree centrality of network nodes in different frequency bands in Parkinson's disease with depression and without depression</article-title>. <source>Front Neurosci.</source> (<year>2021</year>) <volume>15</volume>:<fpage>638554</fpage>. <pub-id pub-id-type="doi">10.3389/fnins.2021.638554</pub-id><pub-id pub-id-type="pmid">33828449</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <label>42.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>CT</given-names></name><name><surname>Su</surname><given-names>TP</given-names></name><name><surname>Wang</surname><given-names>SJ</given-names></name><name><surname>Tu</surname><given-names>PC</given-names></name><name><surname>Hsieh</surname><given-names>JC</given-names></name></person-group>. <article-title>Prefrontal glucose metabolism in medication-resistant major depression</article-title>. <source>Br J Psychiatry.</source> (<year>2015</year>) <volume>206</volume>:<fpage>316</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.bp.113.140434</pub-id><pub-id pub-id-type="pmid">25657357</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <label>43.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunelin</surname><given-names>J</given-names></name><name><surname>Mondino</surname><given-names>M</given-names></name><name><surname>Bation</surname><given-names>R</given-names></name><name><surname>Palm</surname><given-names>U</given-names></name><name><surname>Saoud</surname><given-names>M</given-names></name><name><surname>Poulet</surname><given-names>E</given-names></name></person-group>. <article-title>Transcranial direct current stimulation for obsessive-compulsive disorder: a systematic review</article-title>. <source>Brain Sci.</source> (<year>2018</year>) <volume>8</volume>:<fpage>37</fpage>. <pub-id pub-id-type="doi">10.3390/brainsci8020037</pub-id><pub-id pub-id-type="pmid">29584663</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <label>44.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>CS</given-names></name></person-group>. <article-title>Functional connectivity mapping of the human precuneus by resting state fMRI</article-title>. <source>Neuroimage.</source> (<year>2012</year>) <volume>59</volume>:<fpage>3548</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.11.023</pub-id><pub-id pub-id-type="pmid">22116037</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <label>45.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Wei</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Increased amygdala-paracentral lobule/precuneus functional connectivity associated with patients with mood disorder and suicidal behavior</article-title>. <source>Front Hum Neurosci.</source> (<year>2020</year>) <volume>14</volume>:<fpage>585664</fpage>. <pub-id pub-id-type="doi">10.3389/fnhum.2020.585664</pub-id><pub-id pub-id-type="pmid">33519398</pub-id></mixed-citation>
      </ref>
      <ref id="B46">
        <label>46.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Hou</surname><given-names>Z</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Effect of NEUROG3 polymorphism rs144643855 on regional spontaneous brain activity in major depressive disorder</article-title>. <source>Behav Brain Res.</source> (<year>2021</year>) <volume>409</volume>:<fpage>113310</fpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2021.113310</pub-id><pub-id pub-id-type="pmid">33878431</pub-id></mixed-citation>
      </ref>
      <ref id="B47">
        <label>47.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>B</given-names></name><name><surname>Roberts</surname><given-names>N</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Social support mediates the influence of cerebellum functional connectivity strength on postpartum depression and postpartum depression with anxiety</article-title>. <source>Transl Psychiatry.</source> (<year>2022</year>) <volume>12</volume>:<fpage>54</fpage>. <pub-id pub-id-type="doi">10.1038/s41398-022-01781-9</pub-id><pub-id pub-id-type="pmid">35136017</pub-id></mixed-citation>
      </ref>
      <ref id="B48">
        <label>48.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Altered long- and short-range functional connectivity density associated with poor sleep quality in patients with chronic insomnia disorder: a resting-state fMRI study</article-title>. <source>Brain Behav.</source> (<year>2020</year>) <volume>10</volume>:<fpage>e01844</fpage>. <pub-id pub-id-type="doi">10.1002/brb3.1844</pub-id><pub-id pub-id-type="pmid">32935924</pub-id></mixed-citation>
      </ref>
      <ref id="B49">
        <label>49.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deco</surname><given-names>G</given-names></name><name><surname>Ponce-Alvarez</surname><given-names>A</given-names></name><name><surname>Hagmann</surname><given-names>P</given-names></name><name><surname>Romani</surname><given-names>GL</given-names></name><name><surname>Mantini</surname><given-names>D</given-names></name><name><surname>Corbetta</surname><given-names>M</given-names></name></person-group>. <article-title>How local excitation-inhibition ratio impacts the whole brain dynamics</article-title>. <source>J Neurosci.</source> (<year>2014</year>) <volume>34</volume>:<fpage>7886</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5068-13.2014</pub-id><pub-id pub-id-type="pmid">24899711</pub-id></mixed-citation>
      </ref>
      <ref id="B50">
        <label>50.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name></person-group>. <article-title>Altered long- and short-range functional connectivity density in healthy subjects after sleep deprivations</article-title>. <source>Front Neurol.</source> (<year>2018</year>) <volume>9</volume>:<fpage>546</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2018.00546</pub-id><pub-id pub-id-type="pmid">30061857</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
